Cargando…
Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo
[Image: see text] Exploring the mechanism through which berberine (Ber) reverses the multidrug resistance (MDR) of breast cancer is of great importance. Herein, we used the methyl thiazolyl tetrazolium assay to determine the drug resistance and cytotoxicity of Ber and doxorubicin (DOX) alone or in c...
Autores principales: | Qian, Ke, Tang, Chao-yuan, Chen, Li-ying, Zheng, Shuang, Zhao, Yue, Ma, Li-sha, Xu, Li, Fan, Lu-hui, Yu, Jian-dong, Tan, Hong-sheng, Sun, Ya-lan, Shen, Li-li, Lu, Yang, Liu, Qi, Liu, Yun, Xiong, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153757/ https://www.ncbi.nlm.nih.gov/pubmed/34056218 http://dx.doi.org/10.1021/acsomega.0c06288 |
Ejemplares similares
-
Study on mechanism of elemene reversing tumor multidrug resistance based on luminescence pharmacokinetics in tumor cells in vitro and in vivo
por: Chen, Liying, et al.
Publicado: (2020) -
Effects of berberine on pharmacokinetics of midazolam and rhodamine 123 in rats in vivo
por: Xin, Hua-Wen, et al.
Publicado: (2016) -
Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles
por: Xue, Mei, et al.
Publicado: (2013) -
Effects of Berberine on Atherosclerosis
por: Rui, Rui, et al.
Publicado: (2021) -
In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies
por: Cui, Hanming, et al.
Publicado: (2016)